351 related articles for article (PubMed ID: 28724885)
21. Infiltrating ductal carcinoma developing within cystosarcoma phyllodes--a case report.
Yasumura T; Matsui S; Hamajima T; Nagashima K; Yamagishi H; Aikawa I; Oka T; Nakae T; Shimada N
Jpn J Surg; 1988 May; 18(3):326-9. PubMed ID: 2841520
[TBL] [Abstract][Full Text] [Related]
22. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
[TBL] [Abstract][Full Text] [Related]
23. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
Cheung KJ; Tam W; Chuang E; Osborne MP
Breast J; 2007; 13(4):413-7. PubMed ID: 17593048
[TBL] [Abstract][Full Text] [Related]
24. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
25. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
26. Low-grade adenosquamous carcinoma of the breast: A diagnostic and clinical challenge.
Tan QT; Chuwa EW; Chew SH; Lim-Tan SK; Lim SH
Int J Surg; 2015 Jul; 19():22-6. PubMed ID: 25986061
[TBL] [Abstract][Full Text] [Related]
27. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma.
Crombie N; Rampaul RS; Pinder SE; Elston CW; Robertson JF; Ellis IO
Br J Surg; 2001 Oct; 88(10):1324-9. PubMed ID: 11578285
[TBL] [Abstract][Full Text] [Related]
28. Phyllodes breast tumour showing invasive squamous-cell carcinoma with invasive ductal, clear-cell, secretory, and squamous components.
Ramdass MJ; Dindyal S
Lancet Oncol; 2006 Oct; 7(10):880. PubMed ID: 17012052
[No Abstract] [Full Text] [Related]
29. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
[TBL] [Abstract][Full Text] [Related]
30. Ductal carcinoma in situ with isolated tumor cells in the sentinel lymph node in a 17-year-old adolescent girl.
Sato T; Muto I; Hasegawa M; Aono T; Sakai T; Oya T
Breast Cancer; 2013 Jul; 20(3):271-4. PubMed ID: 20411367
[TBL] [Abstract][Full Text] [Related]
31. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
[TBL] [Abstract][Full Text] [Related]
32. Collision tumor: invasive ductal carcinoma in association with mucosa-associated lymphoid tissue (MALT) lymphoma in the same breast.
Quilon JM; Gaskin TA; Ludwig AS; Alley C
South Med J; 2006 Feb; 99(2):164-7. PubMed ID: 16509555
[TBL] [Abstract][Full Text] [Related]
33. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
34. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
35. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
[TBL] [Abstract][Full Text] [Related]
36. Breast carcinoma and phyllodes tumour: a case series.
Sin EI; Wong CY; Yong WS; Ong KW; Madhukumar P; Tan VK; Thike AA; Tan PH; Tan BK
J Clin Pathol; 2016 Apr; 69(4):364-9. PubMed ID: 26670744
[TBL] [Abstract][Full Text] [Related]
37. Intraductal carcinoma within a phyllodes tumor of the breast: a case report.
Grove A; Deibjerg Kristensen L
Tumori; 1986 Apr; 72(2):187-90. PubMed ID: 3010519
[TBL] [Abstract][Full Text] [Related]
38. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
39. Concomitant phyllodes tumour and homolateral breast cancer.
Auerbach L
Lancet Oncol; 2002 May; 3(5):279. PubMed ID: 12067804
[No Abstract] [Full Text] [Related]
40. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
